TITLE

Platelet shelf-life

PUB. DATE
February 2004
SOURCE
CMAJ: Canadian Medical Association Journal;2/3/2004, Vol. 170 Issue 3, p331
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
Discusses research on a way to prolong the shelf-life of platelets using galactose. Factors attributed to the short shelf-life of platelets; Alteration of the von Willebrand factor; Implication of study findings for storage of platelets.
ACCESSION #
12017424

 

Related Articles

  • Thrombocytopathy and type 2B von Willebrand disease. Ware, Jerry // Journal of Clinical Investigation;Dec2013, Vol. 123 Issue 12, p5004 

    The knowledge gained from "experiments of nature" has always been paramount in identifying key players in pathophysiologic pathways. This is well characterized by naturally occurring bleeding and thrombotic disorders. In most cases, it is the absence of a particular protein that leads to...

  • Aortic Stenosis, von Willebrand Factor, and Bleeding. Sadler, J. Evan // New England Journal of Medicine;7/24/2003, Vol. 349 Issue 4, p323 

    Comments on a study in this issue by Vincentelli and colleagues which focuses on the prevalence of symptomatic defects in von Willebrand factor in patients with aortic stenosis, and provides information about the response of such hemostatic abnormalities to valve replacement. Way that von...

  • von Willebrand Factor—Cleaving Protease in Thrombotic Thrombocytopenic Purpura and the Hemolytic—Uremic Syndrome. Furlan, Miha; Robles, Rodolfo; Galbusera, Miriam; Remuzzi, Giuseppe; Kyrle, Paul A.; Brenner, Brigitte; Krause, Manuela; Scharrer, Inge; Aumann, Volker; Mittler, Uwe; Solenthaler, Max; Lämmle, Bernhard // New England Journal of Medicine;11/26/98, Vol. 339 Issue 22, p1578 

    Background: Thrombotic thrombocytopenic purpura and the hemolytic–uremic syndrome are severe microvascular disorders of platelet clumping with similar signs and symptoms. Unusually large multimers of von Willebrand factor, capable of agglutinating circulating platelets under high shear...

  • Von Willebrand Factor Antigen and Factor XI Activity Levels As Predictors of Bleeding Tendency in Israeli Patients with Von Willebrand's Disease. Brenner, Benjamin; Steinberg, Tamar; Laor, Arieh; Tavori, Shulamit; Tatarsky, Ilana; Lanir, Naomi // Clinical & Applied Thrombosis/Hemostasis;Fall1995, Vol. 1 Issue 4, p260 

    Previous preliminary data and case reports have suggested an association of von Willebrand's disease (vWD) with factor XI deficiency and platelet abnormalities. We have analyzed the prevalence of factor XI deficiency and thrombocytopathy in a cohort of Israeli patients with vWD. Decreased factor...

  • Bernard-Soulier Syndrome In Pregnancy: A Case Report. Osmanagaoglu, Mehmet; Osmanagaoglu, Selen; Bozkaya, Hasan // Internet Journal of Gynecology & Obstetrics;2005, Vol. 4 Issue 2, p2 

    Bernard-Soulier syndrome (BSS) is a rare inherited disorder with giant platelets, thrombocytopenia and a prolonged bleeding time. These abnormalities are caused by genetic defects of the glycoprotein (GP) Ib/IX/V complex that constitutes the von Willebrand factor receptor on the platelet...

  • Bleeding Disorder Basics. Curry, Heather // Pediatric Nursing;Sep/Oct2004, Vol. 30 Issue 5, p402 

    This article focuses on bleeding disorders. The most common genetic bleeding disorder is von Willebrand Disease. Its presence is determined by a gene on chromosome 12. Occasionally it occurs as a new mutation. It affects up to 3% of the world's population, all genders and races. The von...

  • N-acetylcysteine reduces the size and activity of von Willebrand factor in human plasma and mice. Junmei Chen; Reheman, Adili; Gushiken, Francisca C.; Nolasco, Leticia; Xiaoyun Fu; Moake, Joel L.; Heyu Ni; Lopez, José A.; Chen, Junmei; Fu, Xiaoyun; Ni, Heyu; López, José A // Journal of Clinical Investigation;Feb2011, Vol. 121 Issue 2, p593 

    Thrombotic thrombocytopenic purpura (TTP) is a life-threatening disease characterized by systemic microvascular thrombosis caused by adhesion of platelets to ultra-large vWF (ULVWF) multimers. These multimers accumulate because of a deficiency of the processing enzyme ADAMTS13. vWF protein forms...

  • Valproic acid.  // Reactions Weekly;10/14/2006, Issue 1123, p22 

    The article presents case reports involving fifteen children who developed coagulation disorders during treatment with valproic acid for epilepsy. The patients developed different disorders, including platelet dysfunction, von Willebrand disease factor XIII deficiency, hypofibrinogenaemia, and...

  • Acquired von Willebrand Syndrome in Aortic Stenosis. Vincentelli, André; Susen, Sophie; Le Tourneau, Thierry; Six, Isabelle; Fabre, Olivier; Juthier, Francis; Bauters, Anne; Decoene, Christophe; Goudemand, Jenny; Prat, Alain; Jude, Brigitte // New England Journal of Medicine;7/24/2003, Vol. 349 Issue 4, p343 

    Background: Aortic-valve stenosis can be complicated by bleeding that is associated with acquired type 2A von Willebrand syndrome. However, the prevalence and cause of the hemostatic abnormality in aortic stenosis are unknown. Methods: We enrolled 50 consecutive patients with aortic stenosis,...

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics